Create Account

One Health helps you track and understand your health simply.

Create Account

One Health helps you track and understand your health simply.

C5-OH to C8 ratio (3MCC marker)

Immunology & Autoimmune

3-Hydroxyisovalerylcarnitine to octanoylcarnitine ratio3MCC marker ratioC5OH/C8C5-OH/C8 ratio

Review status

Currently under review

Pending specialist review and validation.

What it shows

This test measures the ratio of 3-hydroxyisovalerylcarnitine (often called C5-OH) to octanoylcarnitine (C8) in your blood. It is part of an acylcarnitine profile performed by tandem mass spectrometry, a method that looks at many small molecules involved in energy metabolism.

The ratio helps evaluate how your body breaks down the amino acid leucine and can point to problems in biotin-dependent carboxylase enzymes. It is particularly used as a marker for 3-methylcrotonyl-CoA carboxylase (3MCC) deficiency and related conditions. Doctors use it in newborn screening follow-up and in children or adults when certain metabolic symptoms are present.

Why it matters

A higher-than-expected C5-OH to C8 ratio can suggest a disorder such as 3MCC deficiency or multiple carboxylase deficiency, conditions that affect how the body processes specific nutrients for energy. Finding these disorders early can guide effective steps such as targeted nutrition, carnitine support, or biotin therapy when appropriate, which can reduce episodes of metabolic stress and protect long-term health.

Your clinician may order this test after an abnormal newborn screen, to investigate unexplained vomiting, lethargy, feeding difficulties, low energy, or metabolic acidosis, or to monitor an established metabolic condition. The result also helps distinguish inherited conditions from temporary changes related to diet, intercurrent illness, or maternal factors in newborns.

Understanding your results

Your result is interpreted together with the full acylcarnitine profile, urine organic acids, biotin status, and your symptoms. A result within the expected range is generally reassuring, although your clinician may still follow up if you have ongoing concerns or other tests suggest a metabolic issue.

If the ratio is higher than expected, your care team may repeat the test, assess vitamin use, and consider enzyme studies or genetic testing of MCCC1 and MCCC2. For newborns, maternal testing may also be recommended. Some changes are temporary, especially during illness or when taking certain supplements, so do not start or stop vitamins or medications without medical advice.

Reference ranges

00.4 nan
All sexes
0 days – 150 years

Reference intervals vary by laboratory, analyzer, methodology, population, and units. The ranges shown here are for education only. Always interpret your results against the reference interval printed on your own lab report.

Factors that could impact C5-OH to C8 ratio (3MCC marker)

  • Recent illness or fasting

    Fever, infection, or prolonged fasting can increase catabolic stress and shift acylcarnitine patterns, potentially raising the C5-OH to C8 ratio temporarily.

  • Biotin status and supplements

    High-dose biotin supplements or biotin deficiency can alter carboxylase activity and affect the ratio. Tell your clinician about all vitamins and timing of your last dose.

  • Medications affecting metabolism

    Drugs such as valproate or certain anticonvulsants, and carnitine therapy, can change acylcarnitine profiles. Provide a complete medication list before testing.

  • Sample type and timing

    Whether the sample is a dried blood spot or plasma, the time since last feed, and transport or storage conditions can influence results and their interpretation.

  • Maternal influence in newborns

    In infants, maternal metabolic status, vitamin use, or an unrecognized maternal 3MCC trait can affect the newborn’s ratio, prompting evaluation of the mother as needed.

  • Kidney or liver function

    Impaired renal or hepatic function can change acylcarnitine clearance and metabolism, which may subtly shift this ratio and related markers.

2026

References

  1. McGill University Health Centre. (2018, December 04). C5-OH/C8 3MCC (Task CD 22048162). Laboratory reference ranges.
  2. American College of Medical Genetics and Genomics. (2020). ACT Sheet: Increased C5-OH (hydroxyisovalerylcarnitine) – possible 3-methylcrotonyl-CoA carboxylase deficiency. ACMG.
  3. Vockley, J., & Ensenauer, R. (2006). Isovaleric acidemia and other disorders of leucine metabolism. American Journal of Medical Genetics Part C: Seminars in Medical Genetics, 142C(2), 86–94.